학술논문
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study
Document Type
Article
Author
Source
In European Journal of Cancer May 2023 185:83-93
Subject
Language
ISSN
0959-8049